Eric Dobmeier
Board Member
Janux Therapeutics, Inc. (JANX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Dobmeier
Eric Dobmeier is recorded as Board Member at Janux Therapeutics, Inc. (JANX). Janux Therapeutics, Inc. reported in an 8-K filed April 28, 2026 that Eric Dobmeier was appointed Class II director, effective April 28, 2026. Janux Therapeutics, Inc. reported in an 8-K filed April 28, 2026 that Eric Dobmeier resigned as Class III director, effective April 28, 2026. Janux Therapeutics, Inc. reported in an 8-K filed July 22, 2024 that Eric Dobmeier was appointed Class III director of the Company, effective July 19, 2024.
“Effective immediately following Mr. Dobmeier's resignation, the Board reappointed him as a Class II director.”
“on April 28, 2026, Eric Dobmeier agreed to resign from the Board and his position as a Class III director subject to, and contingent upon, his immediate reappointment as a Class II director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-28–present
-
2026-04-28–2026-04-28
-
2024-07-19–2026-04-28
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Janux Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David Campbell CEO, Board Member
- Ron Barrett, Ph.D. Chairman
- Tighe Reardon CFO
- Alana McNulty Board Member
- Natasha Hernday Board Member
- Ronald Barrett, Ph.D. Board Member
- Winston Kung Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.